Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4267294 | Transplantation Reviews | 2012 | 12 Pages |
Abstract
Nuclear factor (NF) κB is a pleiotropic transcription factor that is ubiquitously expressed. After transplantation of solid organs, NF-κB in the graft is activated within a few hours as a consequence of ischemia/reperfusion and then again after a few days in intragraft infiltrating cells during the process of acute allograft rejection. In the present article, we review the components of the NF-κB pathway, their mechanisms of activation, and their role in T cell and antigen-presenting cell activation and differentiation and in solid organ allograft rejection. Targeted inhibition of NF-κB in selected cell types may promote graft survival with fewer adverse effects compared with global immunosuppressive therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Transplantation
Authors
Luciana L. Molinero, Maria-Luisa Alegre,